Cutaneous and mucous manifestations in hepatobiliary and pancreatic affections;Manifestations cutanéomuqueuses des affections hé patobiliaires et pancréatiques

EMC - Dermatologie-Cosmetologie

Volumn 1, Issue 4, 2004, Pages 165-187

  Delaporte, E ^a   Piette, F ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Cirrhosis; Combined cryoglobulinaemia; Disseminating necrotizing periarteritis; Glucagonoma; Haemochomatosis; Lichen; Pancreatic tumours; Panniculitis; Porphyria cutanea tarda; Viral hepatitis

Indexed keywords

EID: 33645715519     PISSN: 17625696     EISSN: 17625696     Source Type: Journal    
DOI: 10.1016/j.emcdc.2004.10.001     Document Type: Short Survey

References (132)

1. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V, et al. Extrahepatic manifestations associated with hepatitis C virus infection: a prospective multicenter study of 321 patients. Medicine 2000;79:47-56.
2. Jackson JM. Hepatitis C and the skin. Dermatol Clin 2002; 20:449-58.
3. Jones AM, Warken K, Tyring SK. The cutaneous manifestations of viral hepatitis. Dermatol Clin 2002;20:233-47.
4. Cribier B, Noacco G. Urticaire chronique et infections. Ann Dermatol Vénéréol 2003;130:1S43-1S52.
5. Mehregan DR, Hall MJ, Gibson LE. Urticarial vasculitis: a histopathologic and clinical review of 72 cases. J Am Acad Dermatol 1992;26:441-8.
6. Gambichler T, Paech V, Rotterdam S, Stucker M, Boms S, Altmeyer P. Hepatitis B -associated adult-onset Still's disease presenting with neutrophilic urticaria. Eur J Med Res 2003;8:527-30.
7. Caputo R, Gelmetti C, Ermacora E, Gianni E, Silvestri A. Gianotti-Crosti syndrome: a retrospective analysis of 308 cases. J Am Acad Dermatol 1992;26:207-10.
8. Guillevin L, Lhote F, Cohen P, Sauvaget F, Jarrousse B, Lortholary O, et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine 1995;74:238-53.
9. Trepo C, Guillevin L. Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis. J Autoimmun 2001;16: 269-74.
10. Andreu M, Gordien E, Lhote F, Andre MH, Deny P, Guillevin L. La périartérite noueuse, complication immédiate d'une hépatite aiguë virale B. Trois observations. Ann Méd Interne 2003;154:205-8.
11. Tang MB, Liew KV, Ng PP, Tan SH, Ng SK. Cutaneous polyarteritis nodosa associated with precore mutant hepatitis B infection. Br J Dermatol 2003;149:885-6.
12. Daoud MS, Hutton KP, Gibson LE. Cutaneous periarteritis nodosa: a clinicopathological study of 79 cases. Br J Dermotol 1997;136:706-13.
13. Duclos P. Safety of immunization and adverse events following vaccination against hepatitis B. J Hepatol 2003;39: S83-S88.
14. Grotto I, Mandel Y, Ephros M, Ashkenazi I, Shemer J. Major adverse reactions to yeast-derived hepatitis B vaccines-a review. Vaccine 1998;16:329-34.
15. Bohlke K, Davis RL, Marcy SM, Braun MM, DeStefano F, Black SB, et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 2003;112:815-20.
16. Grézard P, Chefaï M, Philippot V, Perrot H, Faisant M. Lupus érythémateux cutané et aphtose buccale après vaccination contre l'hépatite B chez un enfant âgé de 6 ans. Ann Dermatol Venereal 1996;123:657-9.
17. Bourgeais AM, Dore MX, Croue A, Leclech C, Verret JL. Périartérite noueuse cutanée après une vaccination contre l'hépatite B. Ann Dermatol Vénéréol 2003;130:205-7.
18. Schmutz JL, Posth M, Granel F, Trechot P, Barbaud A. Sclérodermie localisée après vaccination contre l'hépatite B. Presse Med 2000;29:1046.
19. Poulton JK, Kauffman CL, Lutz LL, Sina B. Solitary mastocytoma arising at a hepatitis B vaccination site. Cutis 1999;63:37-40.
20. Erbagci Z. Childhood bullous pemphigoid following hepatitis B immunization. J Dermatol 2002;29:781-5.
21. Andiran N, Sentürk GB, Bükülmez G. Combined vaccination by measles and hepatitis B vaccines: a new cause of Gianotti-Crosti syndrome. Dermatology 2002;204:75-6.
22. Limas C, Limas CJ. Lichen planus in children: a possible complication of hepatitis B vaccines. Pediatr Dermatol 2002;19:204-9.
23. Flageul B, Hassan F, Pinquier L, Blanchet-Bardon C, Dubertret L. Lichen pemphigoïde associé à une hépatite B évolutive chez un enfant. Ann Dermatol Vénéréol 1999;126: 604-7.
24. Bessis D, Hellier I, Dereure O, Guilhou JJ. Porphyrie cutanée tardive. Ann Dermatol Vénéréol 2001;128:1068-74.
25. Ferri C, Sebastiani M, Giuggioli D, Cazzato M, Longombardo G, Antonelli A, et al. Mixed cryoglobulinemia: demographic, clinical, and sérologic features and survival in 231 patients. Semin Arthritis Rheum 2004;33:355-74.
26. El-Serag HB, Hampel H, Yeh C, Rabeneck L. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 2002;36:1439-45.
27. Bonkovsky HL, Mehta S. Hepatitis C: a review and update. J Am Acad Dermatol 2001;44:159-79.
28. Cacoub P. Traitement des manifestations extrahépatiques associées au virus de l'hépatite C. Gastroentérol Clin Biol 2002;26:B210-B219.
29. Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, et al. Extrahepatic manifestations in patients with chronic hepatitis C. Arthritis Rheum 1999;42:2204-12.
30. Crowson AN, Nuovo G, Ferri C, Magro CM. The dermatopathologic manifestations of hepatitis C infection: a clinical, histological and molecular assessment of 35 cases. Hum Pothol 2003;34:573-9.
31. Ferri C, Giuggioli D, Cazzato M, Sebastiani M, Mascia MT, Zignego AL. HCV-related cryoglobulinemic vasculitis: an update on its etiopathogenesis and therapeutic strategies. Clin Exp Rheumatol 2003;21(suppl6):S78-S84.
32. Boyer O, Saadoun D, Abriol J, Dodille M, Piette JC, Cacoub P, et al. CD4+ CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood 2004;103:3428-30.
33. Batisse D, Karmochkine M, Jacquot C, Kazatchkine MD, Weiss L. Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peginterferon alfa. Eur J Gastroenterol Hepatol 2004;16: 701-3.
34. Chandesris MO, Gayet S, Schleinitz N, Doudier B, Harle JR, Kaplanski G. Infliximab in the treatment of refractory vasculitis secondary to hepatitis C-associated mixed cryoglobulinaemia. Rheumatology 2004;43:532-3.
35. Lamprecht P, Lerin-Lozano C, Merz H, Dennin RH, Gause A, Voswinkel J, et al. Rituximab induces remission in refractory HCV associated cryoglobulinaemia vasculitis. Ann Rheum Dis 2003;62:1230-3.
36. Güngör E, Cirit A, Alli N, Karakayali G, Gür G, Artüz F. Prevalence of hepatitis C virus antibodies and cryoglobulinemia in patients with leukocytoclastic vasculitis. Dermatology 1999;98:26-8.
37. Cruz-Rojo J, Fontanellas A, Moran-Jimenez MJ, Navarro-Ordonez S, Garcia-Bravo M, Mendez M. Precipitating/aggravating factors of porphyria cutanea tarda in Spanish patients. Cell Mol Biol 2002;48:845-52.
38. Sarkany RP. The management of porphyria cutanea tarda. Clin Exp Dermatol 2001;26:225-32.
39. Jessner W, Der-Petrossian M, Christiansen L, Maier H, Steindl-Munda P, Gangl A, et al. Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C. Hepatology 2002;36:1301-2.
40. Fernandez I, Castellano G, de Salamanca RE, Colina F, Gomez de la Camara A, Moran MJ, et al. Porphyria cutanea tarda as a predictor of poor response to interferon alfa therapy chronic hepatitis C. Scand J Gastroenterol 2003; 38:3149.
41. Carrozzo M, Gandolfo S. Oral diseases possibly associated with hepatitis C virus. Crit Rev Oral Biol Med 2003;14:115-27.
42. Nagao Y, Hanada S, Shishido S, Ide T, Kumashiro R, Ueno T, et al. Incidence of Sjögren's syndrome in Japanese patients with hepatitis C virus infection. J Gastroenterol Hepatol 2003;18:258-66.
43. Hausfater P, Cacoub P, Sterkers Y, Thibault V, Amoura Z, Nguyen L, et al. Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France. Am J Hematol 2001;67:168-71.
44. Viguier M, Rivet J, Agbalika F, Kerviler E, Brice P, Dubertret L, et al. B-cell lymphomas involving the skin associated with hepatitis C virus infection, Int J Dermatol 2002; 41:577-82.
45. Cacoub P, Maisonobe T, Thibault V, Gatel A, Servan J, Musset L, et al. Systemic vasculitis in patients with hepatitis C. J Rheumatol 2001;28:109-18.
46. Soufir N, Descamps V, Crickx B, Thibault V, Cosnes A, Bécherel PA, et al. Hepatitis C virus infection in cutaneous polyarteritis nodosa: a retrospective study of 16 cases. Arch Dermatol 1999;135:1001-2.
47. Kelkar PS, Butterfield JH, Kalaaji AN. Urticarial vasculitis with asymptomatic chronic hepatitis C infection: response to doxepin, interferon-alfa, and ribavirin. J Clin Gastroenterol 2002;35:281-2.
48. Chia SC, Bergasa NV, Kleiner DE, Goodman Z, Hoofnagle JH, Di Bisceglie AM. Pruritus as a presenting symptom of chronic hepatitis C. Dig Dis Sci 1998;43:2177-83.
49. Dega H, Francès C, Dupin N, Lebre C, Simantov A, Callot C, et al. Prurit et virus de l'hépatite C. Ann Dermatol Venereol 1998;125:9-12.
50. Doria C, Mandala L, Smith J, Vitale CH, Lauro A, Gruttadauria S, et al. Effect of molecular adsorbent recirculating system in hepatitis C virus related intractable pruritus. Liver Transpl 2003;9:437-43.
51. Yosipovitch G, Fleischer A. Itch associated with skin disease: advances in pathophysiology and emerging therapies. Am J Clin Dermatol 2003;4:617-22.
52. Garg VK, Karki BM, Agrawal S, Agarwalla A, Gupta R. A study from Nepal showing no correlation between lichen planus and hepatitis C viruses. J Dermatol 2002;29:411-3.
53. Daramola OO, George AO, Ogunbiyi AO. Hepatitis C virus and lichen planus in Nigerians: any relationship? Int J Dermotol 2002;41:217-9.
54. Gimenez-Garcia R, Pérez-Castrillon JL. Lichen planus and hepatitis C virus infection. J Eur Acad Dermatol Venereal 2003;17:291-5.
55. Tousi P, Rahmati M, Khorshid M. Urticaria and hepatitis C infection: is there a relationship? Int J Dermatol 2002;41: 712-3.
56. Brouard M, Borradori L. Red fingers syndrome associated with hepatitis C virus. J Eur Acad Dermatol Venereol 2002;16:187-8.
57. Baz K, Yazici AC, Kaya TI, Ikizoglu G, Ulubas B, Apat DD, et al. Neutrophilic dermatosis of the hands (localized Sweet's syndrome) in association with chronic hepatitis C and sarcoidosis. Clin Exp Dermatol 2003;28:377-9.
58. Okai T, Shirasaki F, Sawabu N. Erythematous maculopapular eruption due to ribavirin administration in a patient with chronic hepatitis C. J Clin Gastroenterol 2003;36: 283-4.
59. Stryjek-Kaminska D, Ochsendorf F, Roder C, Wolter M, Zeuzem S. Photoallergic skin reaction to ribavirin. Am J Gastroenterol 1999;94:1686-8.
60. Wendling J, Descamps V, Grossin M, Marcellin P, Le Bozec P, Belaich S, et al. Sarcoidosis during combined interferon alpha and ribavirin therapy in 2 patients with chronic hepatitis C. Arch Dermatol 2002;138:546-7.
61. Cogrel O, Doutre MS, Marlière V, Beylot-Barry M, Couzigou P, Beylot C. Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection: two cases. Br J Dermatol 2002;146:320-4.
62. Dereure O, Raison-Peyron N, Larrey D, Blanc F, Guilhou JJ. Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients. Br J Dermatol 2002;147:1142-6.
63. Moore MM, Elpern DJ, Carter DJ. Severe, generalized nummular eczema secondary to interferon alfa-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection. Arch Dermatol 2004;140:215-7.
64. Willems M, Munte K, Vrolijk JM, Den Hollander JC, Böhm M, Kemmeren MH, et al. Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection. Br J Dermatol 2003;149:390-4.
65. Misery L. Diffuse hypertrichosis in the course of hepatitis C treatment by IFN-alpha and ribavirin. J Interferon Cytokine Res 2002;22:881-2.
66. Bessis D, Luong MS, Blanc P, Chapoutot C, Larrey D, Guilhou JJ, et al. Straight hair associated with interferon-alfa plus ribavirin in hepatitis C infection. Br J Dermatol 2002; 147:392-3.
67. Pouthier D, Theissen F, Humbel RL. Lupus syndrome, hypothyroidism and bullous skin lesions after interferon alfa therapy for hepatitis C in a haemodialysis patient. Nephrol Dial Transplant 2002;17:174.
68. Smith KE, Fenske NA. Cutaneous manifestations of alcohol abuse. J Am Acad Dermatol 2000;43:1-16.
69. Safa G, Piéto-Le Corvaisier CH, Cadiou C, Pasquiou A, Rivoallan N. Scorbut en l'an 2000: 3 cas. Ann Dermatol Vénéréol 2001;128:1225-8.
70. Delaporte E, Catteau B, Piette F. Necrolytic migratory erythema-like eruption in zinc deficiency associated with alcoholic liver disease. Br J Dermatol 1997;137:1011-2.
71. Meyer N, Roman P. Psoriasis et alcool. Ann Dermatol Venereal 2003;130:409-12.
72. Naldi L, Peli L, Parazzini F. Association of early-stage psoriasis with smoking and male alcohol consumption. Evidence from an Italian case-control study. Arch Dermatol 1999;135:1479-84.
73. Bismuth M, Aguilar-Martinez P, Michel H. L'hémochromatose héréditaire. Presse Méd 2003;32:1716-23.
74. Scotet V, Merour MC, Mercier AY, Chanu B, Le Faou T, Raguenes O, et al. Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation. Am J Epidemiol 2003;158:129-34.
75. Le Gall JY. Faut-il dépister systématiquement l'hémochromatose génétique? Presse Méd 2003;32:1588-90.
76. Skowron F, Bérard F, Grézard P, Wolf F, Morel Y, Perrot H. Rôle du gène de l'hémochromatose (HFE) dans la porphyrie cutanée tardive. Ann Dermatol Vénéréol 2001;128:600-4.
77. Murray KF, Lam D, Kowdley KV. Current and future therapy in haemochromatosis and Wilson's disease. Exp Opm Pharmacother 2003;4:2239-51.
78. Hsi G, Cox DW. A comparison of the mutation spectra of Menkes disease and Wilson disease. Hum Genet 2004;114: 165-72.
79. Gitlin JD, Wilson, disease. Gastroenterology 2003;125: 1868-77.
80. Diris N, Derancourt C, Levy S, Bernardeau K, Durand F, Bernard P. Maladie de Wilson révélée par des signes cutanées. Nouv Dermatol 2002;21:15-7.
81. Bergasa NV. Pruritus and fatigue in primary biliary cirrhosis. Clin Liver Dis 2003;7:879-900.
82. Talwalkar JA, Souto E, Jorgensen RA, Lindor KD. Natural history of pruritus in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2003;1:297-302.
83. Reed JR, De Luca N, McIntyre AS, Wilkinson JD. Localized morphoea, xanthomatosis and primary biliary cirrhosis. Br J Dermatol 2000;143:652-3.
84. Stroehmann A, Dorner T, Lukowsky A, Feist E, Hiepe F, Burmester GR. Cutaneous T cell lymphoma in a patient with primary biliary cirrhosis and secondary Sjogren's syndrome. J Rheumatol 2002;29:1326-9.
85. Szigeti N, Fabian G, Czirjak L. Fatal scleroderma renal crisis caused by gastrointestinal bleeding in a patient with scleroderma, Sjogren's syndrome and primary biliary cirrhosis overlap. J Eur Acad Dermatol Venereal 2002;16: 276-9.
86. Requena L, Yus ES. Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol 2001;45:325-61.
87. Dahl PR, Su WP, Cullimore KC, Dicken CH. Pancreatic panniculitis. J Am Acad Dermatol 1995;33:413-7.
88. Echeverria CM, Fortunato LP, Stengel FM, Laurini J, Diaz C. Pancreatic panniculitis in a kidney transplant recipient, Int J Dermatol 2001;40:751-3.
89. Le Borgne J, Partensky C, De Calan L, Moussu P, Moyon J, Joubert M. Syndrome de Weber-Christian et tumeur intra-canalaire papillaire et mucineuse du pancréas. Gastroenterol Clin Biol 1999;23:281-3.
90. Le Corguillé M, Levy P, Nahon S, Ponsot P, Hammel P, Delas N, et al. Syndrome de Weber-Christian dû à une fistule pancréatico-mésentérique supérieure au décours d'une pancréatite aiguë alcoolique. Gastroentérol Clin Biol 2003;27:660-2.
91. Corazza M, Salmi R, Strumia R. Pancreatic panniculitis as a first sign of liver carcinoma. Acta Derm Venereol 2003;83: 230-1.
92. McBean J, Sable A, Maude J, Robinson-Bostom L. Alpha-1-antitrypsin deficiency panniculitis. Cutis 2003;71:205-9.
93. Luisetti M, Seersholm N. Alpha-1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency. Thorax 2004;59:164-9.
94. Chowdhury MM, Williams EJ, Morris JS, Ferguson BJ, McGregor AD, Hedges AR, et al. Severe panniculitis caused by homozygous ZZ α1-antitrypsin deficiency treated successfully with human purified enzyme (Prolastin®). Br J Dermatol 2002;147:1258-61.
95. Bem J, Bradley 3rd EL. Subcutaneous manifestations of severe acute pancreatis. Pancreas 1998;16:551-5.
96. Gould JW, Helms SE, Schulz SM, Stevens SR. Relapsing livedo reticularis in the setting of chronic pancreatis. J Am Acad Dermatol 1998;39:1035-6.
97. Heykarts B, Anseeuw M, Degreef H. Panniculitis caused by acinous pancreatic carcinoma. Dermatology 1999;198: 182-3.
98. Preiss JC, Faiss S, Loddenkemper C, Zeitz M, Duchmann R. Pancreatic panniculitis in an 88-year-old man with neuroendocrine carcinoma. Digestion 2002;66:193-6.
99. Rulyak SJ, Brentnall TA, Lynch HT, Austin MA. Characterization of the neoplastic phenotype in the familial atypical multiple-mole melanoma-pancreatic carcinoma syndrome. Cancer 2003;98:798-804.
100. Denko NC, Giaccia AJ. Tumor hypoxia, the physiological link between Trousseau's syndrome (carcinoma-induced coagulopathy) and metastasis. Cancer Res 2001;61:795-8.
101. Bessis D, Porneuf M, Dandurand M, Ramos J, Ciurana AJ. Superficial migratory thrombophlebitis. Eur J Dermatol 1993;3:480-3.
102. Pfinsgraff J, Buckingham RB, Killian PJ, Keister SR, Brereton WF, Weinblatt ME, et al. Palmar fasciitis and arthritis with malignant neoplasms: a paraneoplastic syndrome. Semin Arthritis Rheum 1986;16:118-25.
103. Cox NH, Ramsay B, Dobson C, Comaish JS. Woody hands in a patient with pancreatic carcinoma: a variant of cancer-associated fasciitis-panniculitis syndrome. Br J Dermatol 1996;135:995-8.
104. Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol 1993;29:228-36.
105. Takeuchi H, Kawano T, Toda T, Minamisono Y, Nagasaki S, Yao T, et al. Cutaneous metastasis from pancreatic adenocarcinoma: a case report and a review literature. Hepatogastroenterology 2003;50:275-7.
106. Dubreuil A, Dompmartin A, Barjot P, Louvet S, Leroy D. Umbilical metastasis or sister Mary Joseph's nodule, Int J Dermotol 1998;37:7-13.
107. Florez A, Roson E, Sanchez-Aguilar D, Peteiro C, Toribio J. Solitary cutaneous metastasis on the buttock: a disclosing sign of pancreatic adenocarcinoma. Clin Exp Dermatol 2000;25:201-3.
108. Fiori E, Galati G, Bononi M, De Cesare A, Binda B, Ciardi A, et al. Subcutaneous metastasis of pancreatic cancer in the site of percutaneous biliary drainage. J Exp Clin Cancer Res 2003;22:151-4.
109. Marty C, Bennet A, Bayle P, Danjoux M, Lalande T, Marguery MC, et al. Érythème nécrolytique migrateur révélateur d'un glucagonome sans diabète. Ann Méd Interne 2003;154:552-6.
110. Pujol RM, Wang CY, El-Azhary RA, Su WP, Gibson L, Schroeter AL. Necrolytic migratory erythema: clinicopathologic study of 13 cases. Int J Dermatol 2004;43:12-8.
111. Johnson SM, Smoller BR, Lamps LW, Horn TD. Necrolytic migratory erythema as the only presenting sign of a glucagonoma. J Am Acad Dermatol 2003;49:325-8.
112. Chastain MA. The glucagonoma syndrome: a review of its features and discussion of new perspectives. Am J Med Sci 2001;321:306-20.
113. Wermers RA, Fatourechi V, Wynne AG, Kvols LK, Lloyd RV. The glucagonoma syndrome: clinical and pathologic features in 21 patients. Medicine 1996;75:53-63.
114. Adam DN, Cohen PD, Sibbald RG, Ghazarian D. Necrolytic migratory erythema: case report and clinical review. J Cutan Med Surg 2003;7:333-8.
115. Schwartz RA. Glucagonoma and pseudoglucagonoma syndromes, Int J Dermatol 1997;36:81-9.
116. Brentjens R, Saltz L. Islet cell tumors of the pancreas: the medical oncologist's perspective. Surg Clin North Am 2001;81:527-42.
117. Soga J, Yakuwa Y. Glucagonomas/diabetico-dermatogenic syndrome (DDS): a statistical evaluation of 407 reported cases. J Hepatobiliary Pancreatic Surg 1998;5:312-9.
118. Nishiguchi S, Shiomi S, Ishizu H, Iwata Y, Kurooka H, Minamitani S, et al. A case of glucagonoma with high uptake on F-18 fluorodeoxyglucose positron emission tomography. Ann Nucl Med 2001;15:259-62.
119. Alexander EK, Robinson M, Staniec M, Dluhy RG. Peripheral amino acid and fatty acid infusion for the treatment of necrolytic migratory erythema in the glucagonoma syndrome. Clin Endocrinol 2002;57:827-31.
120. Case CC, Vassilopoulou-Sellin R. Reproduction of features of the glucagonoma syndrome with continuous intravenous glucagon infusion as therapy for tumor-induced hypoglycemia. Endocr Pract 2003;9:22-5.
121. Chao SC, Lee JY. Brittle nails and dyspareunia as first clues to recurrences of malignant glucagonoma. Br J Dermatol 2002;146:1071-4.
122. Sinclair SA, Reynolds NJ. Necrolytic migratory erythema and zinc deficiency. Br J Dermatol 1997;136:783-5.
123. Blackford S, Wright S, Roberts DI. Necrolytic migratory erythema without glucagonoma: the role of dietary essential fatty acids. Br J Dermatol 1991;125:460-2.
124. Gaveau D, Piette F, Cortot A, Dumur V, Bergoend H. Manifestations cutanées du déficit en zinc dans la cirrhose éthylique. Ann Dermatol Vénéréol 1987;114:39-53.
125. Mullans EA, Cohen PR. Iatrogenic necrolytic migratory erythema: a case report and review of nonglucagonoma-associated necrolytic migratory erythema. J Am Acad Dermatol 1998;38:866-73.
126. Khanna VJ, Shieh S, Benjamin J, Somach S, Zaim MT, Dorner W, et al. Necrolytic acral erythema associated with hepatitis C. Effective treatment with interferon alfa and zinc. Arch Dermatol 2000;136:755-7.
127. Hivnor CM, Van AC, Junkins-Hopkins MJ, Honig PJ. Necrolytic acral erythema: response to combination therapy with interferon and ribavirin. J Am Acad Dermatol 2004; 50(suppl5):S121-S124.
128. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumours. Cancer 1997;79:813-29.
129. Migliori M, Tomassetti P, Lalli S, Casadei R, Santini D, Corinaldesi R, et al. Carcinoid of the pancreas. Pancreatology 2002;2:163-6.
130. Saint-Marc O, Cogliandolo A, Pozzo A, Pidoto RR. A primary pancreatic carcinoid tumour with unusual clinical complaints: a case report. World J Surg Oncol 2004;2:3.
131. Beuschlein F, Hammer GD. Ectopic pro-opiomelanocortin syndrome. Endocrinol Metab Clin North Am 2002;31:191-234.
132. Zhang Y, Selvaggi SM. Metastatic islet cell carcinoma to the umbilicus: diagnosis by fine-needle aspiration. Diagn Cytopathol 2003;29:91-4.